Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.

scientific article

Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000453364
P932PMC publication ID5729946
P698PubMed publication ID29255745

P2093author name stringSusana Lopes
Susana Rodrigues
Eduardo Rodrigues-Pinto
Guilherme Macedo
Joanne Lopes
Patrícia Andrade
Rui Gaspar
P2860cites workThe diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysisQ30497534
The burden of liver disease in Europe: a review of available epidemiological dataQ30590517
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysisQ30592294
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.Q31040495
Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver diseaseQ33716857
Steatosis: co-factor in other liver diseases.Q36165987
Nonalcoholic fatty liver disease: from steatosis to cirrhosisQ36382279
The epidemiology of nonalcoholic fatty liver disease: a global perspectiveQ37310275
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonanceQ37552186
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patientsQ37724690
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connectionQ37739949
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroscanQ37932842
Noninvasive assessment of liver steatosis using ultrasound methodsQ38238765
Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.Q40467529
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United StatesQ41626076
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver diseaseQ43786789
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?Q45206614
Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.Q46877112
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.Q51171810
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective StudyQ51541188
Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.Q51655382
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastographyQ57735439
P433issue4
P921main subjectsteatosisQ1365091
chronic liver diseaseQ5113984
P304page(s)161-168
P577publication date2016-12-23
P1433published inGE: Portuguese Journal of GastroenterologyQ50817053
P1476titleDiagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.
P478volume24

Reverse relations

cites work (P2860)
Q54760091Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance?
Q64936053Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter.
Q92900970New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode
Q92829495Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension
Q91552287Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance
Q91638348Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency

Search more.